年轻人体质指数和慢性阻塞性肺病之间的关联:全国性基于人口的队列研究
Chiwook Chung1, Hajeong Kim2, Kyu Na Lee3
1Department of Pulmonary and Critical Care Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
Scientific reports
|December 31, 2024
概括
在年轻人中,体重不足会增加慢性阻塞性肺病 (COPD) 的风险. 相反,超重和肥胖与该年龄组的COPD风险降低有关.
科学领域:
- 肺部医学 肺部医学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 体重指数 (BMI) 是与慢性阻塞性肺病 (COPD) 风险相关的已知因素.
- 了解BMI在年轻人中COPD发展中的作用对于早期干预策略至关重要.
研究的目的:
- 研究身体质量指数 (BMI) 与20-39岁年轻人患慢性阻塞性肺病 (COPD) 的风险之间的关联.
主要方法:
- 利用韩国国家健康信息数据库识别了6,304,769名年龄在20-39岁之间的个人.
- 采用多变量Cox比例危险模型来分析COPD发展的风险因素.
- 根据亚洲BMI标准对BMI进行分类,以评估体重不足,正常,超重和肥胖的群体.
主要成果:
- 体重不足 (BMI <18.5 kg/m2) 的个人表现出明显更高的COPD发展风险 (aHR: 1.37).
- 超重 (BMI 23-24.9 kg/m2) 和肥胖 (BMI 25-29.9 kg/m2) 个体表现出COPD风险降低 (aHR:两者均为0.90).
- 一个值得注意的发现是女性BMI上升的风险增加,与男性观察到的一般趋势不同.
结论:
- 在年轻人中,体重不足是发展COPD的危险因素.
- 相反,年轻成人超重或肥胖与慢性肺炎风险降低有关.
- 该研究强调了BMI-COPD关联的性别特异性差异,并表明,较高的BMI对COPD的保护作用可能会在非吸烟者中减弱.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Lung Capacity
49.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
49.3K


